Compositions and methods for preventing and treating transplant rejection
CA 2385312 C · Owner: Lucas, Alexandra · Inventors: Zhong, Robert; Mcfadden, Grant D.; Lucas, Alexandra
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compositions and methods for treating transplant rejection in a mammalian transplant recipient are provided. The method involves administering a therapeutically effective amount of Serp-1 its analogs, and biologically , active fragments thereof in combination with an anti-rejection agent such as , cyclosporin, and a pharmaceutically acceptable carrier to a subject in need of such treatment. The compositions and methods are useful for treating acute and chronic allograft and xenograft transplant rejection in mammals.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 27, 2000 and granted February 7, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 27, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 27, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.